首页> 外文期刊>Cancer chemotherapy and pharmacology. >Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins
【24h】

Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins

机译:抑制山梨素通过调节细胞凋亡相关蛋白逆转K562 / A02细胞和MCF-7 / A02细胞的多药耐药性

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: Sorcin, a 22-kDa calcium-binding protein, renders cancer cells resistant to chemotherapeutic agents, thus playing an important role in multidrug resistance (MDR). But the mechanisms mediated by sorcin still remain quite elusive. This study aim to explore whether sorcin silencing could restore chemosensitivity in MDR cancer cells and seek to identify the functional mechanisms mediated by sorcin. Methods: To investigate the mechanisms of sorcin-silencing-induced chemosensitivity, transient expression of sorcin-siRNAs was performed in doxorubicin-induced MDR cell lines, K562/A02 and MCF-7/A02. Sensitivity to five chemotherapeutic agents was evaluated by analysis of cell survival and cell apoptosis. Results: In this report, we show that down-regulation of sorcin did not alter expression or function of P-gp, but actually induced cell apoptosis and chemosensitivity in K562/A02 and MCF-7/A02. We also observe that silencing of sorcin-enhanced chemotherapeutic agent effects partly through regulating apoptosis-related protein, including Bcl-2, Bax, c-jun and c-fos. Conclusion: This offers the rationale for the development of therapeutic strategies down-regulating sorcin expression for the treatment of cancer, especially for the reversal of MDR.
机译:目的:Sorcin是一种22 kDa的钙结合蛋白,可使癌细胞对化学治疗剂产生抗性,从而在多药耐药性(MDR)中发挥重要作用。但是,由山梨素介导的机制仍然很不清楚。这项研究的目的是探讨是否使山梨素沉默能够恢复MDR癌细胞的化学敏感性,并试图确定山梨素介导的功能机制。方法:为研究索霉素沉默引起的化学敏感性的机制,在阿霉素诱导的MDR细胞系K562 / A02和MCF-7 / A02中瞬时表达sorcin-siRNA。通过分析细胞存活和细胞凋亡来评估对五种化学治疗剂的敏感性。结果:在此报告中,我们显示山梨素的下调并没有改变P-gp的表达或功能,但实际上诱导了K562 / A02和MCF-7 / A02中的细胞凋亡和化学敏感性。我们还观察到,沉默的增强了山梨素的化学治疗剂的作用部分是通过调节凋亡相关蛋白,包括Bcl-2,Bax,c-jun和c-fos。结论:这为开发下调山梨素表达以治疗癌症,特别是逆转MDR的治疗策略提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号